NCT Number: NCT03049865
Gait Speed at Discharge as a Marker for Readmission
The principal aim is to assess if a simple test, the time it takes to walk 10 meters for a patient about to be discharged after a hospital stay for an acute illness, is related to the risk of readmission.
Trial opening soon.
Get NotifiedKey information
Age range
51 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- >50 years of age Patient discharged to home, or temporary short stay nursing home Expected survival >90 days The ability to read or understand the instructions and to give informed consent.
Exclusion criteria
- Planned hospital stay, i.e. the patient was admitted electively The including investigator is directly involved in the care of the patient
Treatment and study plan
Primary outcomes
-
Readmission
Time frame: 30 days
Secondary outcomes
-
Readmissions
Time frame: 90,180, 365 days
-
All-cause mortality
Time frame: 6, 12, 24, 36, 60 months
Sponsors and collaborators
Lead sponsor
Karolinska University Hospital
Other
Registry information
Official study title
Gait Speed at Discharge as a Marker for Readmission - The GASP Study
Acronym: GASP
Important dates
- Study start
- 2017
- Primary completion
- 2017
- Study completion
- 2027
- First posted
- Feb 10, 2017
- Registry last updated
- Feb 10, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.